Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Tanzania?
GlobalGov holds 169 pharmaceuticals records from 137 distinct buying organisations in Tanzania. The most frequent publishers are Bombambili Dispensary (5 records); Halla Dispensary (4 records); Tanga Regional Referral Hospital (4 records); Kimeya Health Center (3 records); Mbinga Town Council District Hospital (3 records); Buchosa District Hospital (2 records). Between them the 6 largest account for 12% of everything published, so buying here is spread across many separate authorities.
| Buying organisation | Records | Share |
|---|---|---|
| Bombambili Dispensary | 5 | 3.0% |
| Halla Dispensary | 4 | 2.4% |
| Tanga Regional Referral Hospital | 4 | 2.4% |
| Kimeya Health Center | 3 | 1.8% |
| Mbinga Town Council District Hospital | 3 | 1.8% |
| Buchosa District Hospital | 2 | 1.2% |
How long do bidders get to respond to pharmaceuticals tenders in Tanzania?
Across the 84 Tanzania pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 2 days. A quarter of them allowed 2 days or fewer and a quarter stayed open for more than 2. 84 of them (100%) closed within a fortnight of being published, so on this market a bidder who reviews notices once a week can lose most of the response window before reading one.
How often are pharmaceuticals tenders published in Tanzania?
Tanzania publishes about 12 notices a month in this category, 150 in the last twelve months. That is 900% more than the 15 published in the twelve months before that. Over the last three years there were 169, spread across 15 separate months of activity since 4 January 2024. March is historically the busiest month. No new notice has been published in this category since 9 February 2026, 234 days ago, so treat the figures above as a record of the market rather than as this week's pipeline.
How does Tanzania compare with other pharmaceuticals markets?
Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Tanzania ranks 26th by number of records. The largest is Germany (4,115 records against 169 here). Within Tanzania itself, pharmaceuticals is the 7th largest of the 11 procurement categories tracked here.
Where do the Tanzania pharmaceuticals records on this page come from?
These 169 records are collected from 2 official sources: the Tanzania PPRA (168), the World Bank (1). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Tanzania
No individual notice in this category currently has a public record page. The market figures above are computed over all 169 records GlobalGov holds for it.
Other procurement categories in Tanzania
Pharmaceuticals procurement in other markets
Never Miss a Tanzania Government Contract
Finding Tanzania tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial